Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia.

Abstract:

:Persistent bronchial dysplasia is associated with increased risk of developing invasive squamous cell carcinoma (SCC) of the lung. In this study, we hypothesized that differences in gene expression profiles between persistent and regressive bronchial dysplasia would identify cellular processes that underlie progression to SCC. RNA expression arrays comparing baseline biopsies from 32 bronchial sites that persisted/progressed to 31 regressive sites showed 395 differentially expressed genes [ANOVA, FDR ≤ 0.05). Thirty-one pathways showed significantly altered activity between the two groups, many of which were associated with cell-cycle control and proliferation, inflammation, or epithelial differentiation/cell-cell adhesion. Cultured persistent bronchial dysplasia cells exhibited increased expression of Polo-like kinase 1 (PLK1), which was associated with multiple cell-cycle pathways. Treatment with PLK1 inhibitor induced apoptosis and G2-M arrest and decreased proliferation compared with untreated cells; these effects were not seen in normal or regressive bronchial dysplasia cultures. Inflammatory pathway activity was decreased in persistent bronchial dysplasia, and the presence of an inflammatory infiltrate was more common in regressive bronchial dysplasia. Regressive bronchial dysplasia was also associated with trends toward overall increases in macrophages and T lymphocytes and altered polarization of these inflammatory cell subsets. Increased desmoglein 3 and plakoglobin expression was associated with higher grade and persistence of bronchial dysplasia. These results identify alterations in the persistent subset of bronchial dysplasia that are associated with high risk for progression to invasive SCC. These alterations may serve as strong markers of risk and as effective targets for lung cancer prevention.Significance: Gene expression profiling of high-risk persistent bronchial dysplasia reveals changes in cell-cycle control, inflammatory activity, and epithelial differentiation/cell-cell adhesion that may underlie progression to invasive SCC. Cancer Res; 78(17); 4971-83. ©2018 AACR.

journal_name

Cancer Res

journal_title

Cancer research

authors

Merrick DT,Edwards MG,Franklin WA,Sugita M,Keith RL,Miller YE,Friedman MB,Dwyer-Nield LD,Tennis MA,O'Keefe MC,Donald EJ,Malloy JM,van Bokhoven A,Wilson S,Koch PJ,O'Shea C,Coldren C,Orlicky DJ,Lu X,Baron AE,Hickey

doi

10.1158/0008-5472.CAN-17-3822

subject

Has Abstract

pub_date

2018-09-01 00:00:00

pages

4971-4983

issue

17

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-17-3822

journal_volume

78

pub_type

杂志文章
  • Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.

    abstract::Recent investigations have documented that constitutively activated phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling is a common feature of T-cell acute lymphoblastic leukemia (T-ALL), where it strongly influences growth and survival. These findings lend compelling weight for the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4884

    authors: Chiarini F,Falà F,Tazzari PL,Ricci F,Astolfi A,Pession A,Pagliaro P,McCubrey JA,Martelli AM

    更新日期:2009-04-15 00:00:00

  • A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis.

    abstract::Aneuploidy is invariably associated with poor proliferation of primary cells, but the specific contributions of abnormal karyotypes to cancer, a disease characterized by aneuploidy and dysregulated proliferation, remain unclear. In this study, I demonstrate that the transcriptional alterations caused by aneuploidy in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0749

    authors: Sheltzer JM

    更新日期:2013-11-01 00:00:00

  • Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities.

    abstract::Inhibition of constitutive active signaling pathways, which are a characteristic phenomenon for many tumors, can be an effective therapeutic strategy. In contrast, oncogenic transcription factors, often activated by mutational events, are in general less amenable to small-molecule inhibition despite their obvious impo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2447

    authors: Amstutz R,Wachtel M,Troxler H,Kleinert P,Ebauer M,Haneke T,Oehler-Jänne C,Fabbro D,Niggli FK,Schäfer BW

    更新日期:2008-05-15 00:00:00

  • Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

    abstract::In the present study, we report the characterization of the p53 tumor suppressor pathway in the 60 cell lines of the National Cancer Institute (NCI) anticancer drug screen, as well as correlations between the integrity of this pathway and the growth-inhibitory potency of 123 anticancer agents in this screen. Assessmen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: O'Connor PM,Jackman J,Bae I,Myers TG,Fan S,Mutoh M,Scudiero DA,Monks A,Sausville EA,Weinstein JN,Friend S,Fornace AJ Jr,Kohn KW

    更新日期:1997-10-01 00:00:00

  • Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy.

    abstract::One major rationale for using interleukin-2 and IFN-alpha in cancer immunotherapy is to activate tumor-specific T cells at the tumor site. To study the in situ T-cell response, we determined the T-cell receptor (TCR) repertoire in six melanoma metastases regressing after cytokine treatment obtained from five patients....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Willhauck M,Scheibenbogen C,Pawlita M,Möhler T,Thiel E,Keilholz U

    更新日期:2003-07-01 00:00:00

  • A clinical evaluation of serum C3DP levels in individuals with malignant diseases.

    abstract::A human serum DNA-binding protein (C3DP) derived from complement component C3 has been found in elevated concentrations in the sera of individuals with malignant diseases. An assay system has been devised which reveals quantitative values of serum C3DP levels. Results obtained using this system indicate that normal hu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Parsons RG,Longmire RL,Hoch SO,Hoch JA

    更新日期:1977-03-01 00:00:00

  • Induction, activation, and inhibition of hamster and rat liver microsomal arylamide and arylamine N-hydroxylase.

    abstract::By applying a new and highly sensitive assay for measuring N-hydroxy metabolites, the biochemical properties of the microsomal N-hydroxylase from control and 3-methylcholanthrene-treated rat and hamster liver have been analyzed, and the following conclusions have been drawn. (a) Due to a difference in enzyme affinity,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Razzouk C,Mercier M,Roberfroid M

    更新日期:1980-10-01 00:00:00

  • Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys.

    abstract::The pharmacokinetic disposition of tiazofurin in plasma and cerebrospinal fluid was examined in rhesus monkeys. Tiazofurin was readily detectable in both plasma and cerebrospinal fluid within 20 min of commencement and for 24 h after a short i.v. infusion of the drug. The mean clearance of tiazofurin from plasma was 7...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Grygiel JJ,Balis FM,Collins JM,Lester CM,Poplack DG

    更新日期:1985-05-01 00:00:00

  • Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells.

    abstract::Recently, we have reported that the toxicity of the membrane-active agent valinomycin (VM) can be reduced with maintenance and/or enhancement of its antitumor activity by incorporation in liposomes (S. S. Daoud and Juliano, Cancer Res., 46:5518-5525, 1986). Since the underlying defect(s) in multidrug resistance reside...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Daoud SS,Juliano RL

    更新日期:1989-05-15 00:00:00

  • Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.

    abstract::Galectin-3 (Gal-3), a pleiotropic carbohydrate-binding protein, is a selective binding partner of activated K-Ras-GTP. Because both proteins are antiapoptotic and associated with cancer progression, we questioned the possible functional role of Gal-3 in K-Ras activation. We found that overexpression of Gal-3 in human ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0775

    authors: Shalom-Feuerstein R,Cooks T,Raz A,Kloog Y

    更新日期:2005-08-15 00:00:00

  • Imaging active urokinase plasminogen activator in prostate cancer.

    abstract::The increased proteolytic activity of membrane-bound and secreted proteases on the surface of cancer cells and in the transformed stroma is a common characteristic of aggressive metastatic prostate cancer. We describe here the development of an active site-specific probe for detecting a secreted peritumoral protease e...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2185

    authors: LeBeau AM,Sevillano N,Markham K,Winter MB,Murphy ST,Hostetter DR,West J,Lowman H,Craik CS,VanBrocklin HF

    更新日期:2015-04-01 00:00:00

  • Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.

    abstract::A phenolic amine compound, 4-S-cysteaminylphenol (4-S-CAP), is a potent depigmenting agent. To develop more efficacious antimelanoma agents, we synthesized four homologues of 4-S-CAP: N-acetyl-4-S-CAP (N-Ac-4-S-CAP), alpha-methyl-4-S-CAP, 4-S-homo-CAP, and N,N'-dimethyl-4-S-CAP. We tested these five compounds in mice ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alena F,Jimbow K,Ito S

    更新日期:1990-06-15 00:00:00

  • SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.

    abstract::SOX9 is a member of the SOX [Sry-related high-mobility group (HMG) box] family of HMG DNA-binding domain transcription factors and is required for the development and differentiation of multiple cell lineages. This report shows that basal epithelial cells express SOX9 in normal prostate, with no detectable expression ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1672

    authors: Wang H,McKnight NC,Zhang T,Lu ML,Balk SP,Yuan X

    更新日期:2007-01-15 00:00:00

  • Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

    abstract::The mutational spectrum of the p53 gene was analyzed in 53 hepatocellular carcinomas. Somatic mutations of the p53 gene were detected in 17 cases (32%). Among these 17 mutations, 9 were missense mutations; the mutations in the other 8 cases were nonsense mutations, deletions, or mutations at the intron-exon junctions....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nishida N,Fukuda Y,Kokuryu H,Toguchida J,Yandell DW,Ikenega M,Imura H,Ishizaki K

    更新日期:1993-01-15 00:00:00

  • Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.

    abstract::Murine monoclonal antibodies have been developed against human colorectal tumors using immunogens consisting of extracts from xenografted human colon carcinoma bound to lectin-conjugated agarose beads. Antibodies of the IgG3 isotype were selected from the resulting fusions, since we and other investigators have report...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Woodhouse CS,Morgan AC Jr

    更新日期:1989-05-15 00:00:00

  • Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.

    abstract::Insulin and insulin-like growth factors (IGFs) stimulate the growth of human breast cancer cells in vitro. The type I somatomedin receptor (SR), expressed in these cells, may mediate the mitogenic effects of these peptides. We have examined the effect of type I SR blockade on human breast cancer growth with a monoclon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Arteaga CL,Osborne CK

    更新日期:1989-11-15 00:00:00

  • Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma.

    abstract::Cells lacking the tumor suppressor gene LKB1/STK11 alter their metabolism to match the demands of accelerated growth, leaving them highly vulnerable to stress. However, targeted therapy for LKB1-deficient cancers has yet to be reported. In both Kras/p53/Lkb1 cell lines and a genetically engineered mouse model of Kras/...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0567

    authors: Liu Y,Li Y,Wang X,Liu F,Gao P,Quinn MM,Li F,Merlino AA,Benes C,Liu Q,Gray NS,Wong KK

    更新日期:2017-09-15 00:00:00

  • Peptide-Drug Conjugate GnRH-Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth.

    abstract::The potential to heighten the efficacy of antiangiogenic agents was explored in this study based on active targeting of tumor cells overexpressing the gonadotropin-releasing hormone receptor (GnRH-R). The rational design pursued focused on five analogues of a clinically established antiangiogenic compound (sunitinib),...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2138

    authors: Argyros O,Karampelas T,Asvos X,Varela A,Sayyad N,Papakyriakou A,Davos CH,Tzakos AG,Fokas D,Tamvakopoulos C

    更新日期:2016-03-01 00:00:00

  • Reduced toxicity and enhanced antitumor effects in mice of the ionophoric drug valinomycin when incorporated in liposomes.

    abstract::Valinomycin (NSC 122023) is a cyclic depsipeptide antibiotic with potassium selective ionophoric activity. This drug has been reported to display antitumor effects but its utilization has been limited by its extreme toxicity. Here we report that the incorporation of valinomycin into multilamellar liposomes composed of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Daoud SS,Juliano RL

    更新日期:1986-11-01 00:00:00

  • Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.

    abstract::Hexosaminidase activity in prostatic tissue has been compared in 15 patients with benign prostatic hyperplasia and 15 patients with prostatic carcinoma. The ratio of enzymatic activity for the two substrates tested (p-nitrophenyl-2-acetamido-2-deoxy-beta-D-glucopyranoside and p-nitrophenyl-2-acetamido-2-deoxy-beta-D-g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Whitehurst GB,Mashburn JP,Pretlow TG 2nd,Bradley EL Jr,Boohaker EA

    更新日期:1982-10-01 00:00:00

  • Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.

    abstract::The N-myc gene is transiently expressed during normal embryonic development and abnormally expressed in several tumors of neuroendocrine origin. Little is known of the function of the N-myc gene product in either normal or neoplastic tissue. We utilized synthetic antisense oligodeoxynucleotides to specifically inhibit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosolen A,Whitesell L,Ikegaki N,Kennett RH,Neckers LM

    更新日期:1990-10-01 00:00:00

  • A randomized trial of dietary intervention for breast cancer prevention.

    abstract::Epidemiologic data and animal experiments suggest that dietary fat may influence risk of breast cancer. To determine whether intervention with a low-fat, high-carbohydrate diet would reduce breast cancer incidence in women at increased risk of the disease, we carried out a randomized controlled trial in Canada. We rec...

    journal_title:Cancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.1158/0008-5472.CAN-10-1436

    authors: Martin LJ,Li Q,Melnichouk O,Greenberg C,Minkin S,Hislop G,Boyd NF

    更新日期:2011-01-01 00:00:00

  • Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.

    abstract::The clinical management of cutaneous melanoma would benefit significantly from a better understanding of the molecular changes that occur during melanocytic progression to a melanoma phenotype. To gain unique insights into this process, we developed a three-dimensional in vitro model that allows observations of normal...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2497

    authors: Seftor EA,Brown KM,Chin L,Kirschmann DA,Wheaton WW,Protopopov A,Feng B,Balagurunathan Y,Trent JM,Nickoloff BJ,Seftor RE,Hendrix MJ

    更新日期:2005-11-15 00:00:00

  • In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.

    abstract::RS7, a murine IgG1 antibody raised against human lung carcinoma, possesses pancarcinoma reactivity. The antigen defined by this antibody is present in tumors of the lung, stomach, bladder, breast, ovary, uterus, and prostate. Efficient targeting and therapy by radiolabeled RS7 has been demonstrated previously in anima...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shih LB,Xuan H,Aninipot R,Stein R,Goldenberg DM

    更新日期:1995-12-01 00:00:00

  • Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.

    abstract::Studies of V79-171 cells were undertaken to determine what extracellular or intracellular derivative of the drug WR-2721 is associated with radioprotection. The effect of preincubation at 23 +/- 1 degree C with WR-2721, and with derivatives of WR-2721 produced in medium containing alkaline phosphatase, upon survival o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smoluk GD,Fahey RC,Calabro-Jones PM,Aguilera JA,Ward JF

    更新日期:1988-07-01 00:00:00

  • Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells.

    abstract::Metastatic prostate cancer continues to pose a difficult therapeutic challenge. Prostate cancer progression is associated with aberrant O-glycosylation of cancer cell surface receptors, but the functional impact of such events is uncertain. Here we report spontaneous metastasis of human prostate cancer xenografts that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-0641

    authors: Tsai CH,Tzeng SF,Chao TK,Tsai CY,Yang YC,Lee MT,Hwang JJ,Chou YC,Tsai MH,Cha TL,Hsiao PW

    更新日期:2016-10-01 00:00:00

  • Wnt/PCP Signaling Contribution to Carcinoma Collective Cell Migration and Metastasis.

    abstract::Our understanding of the cellular mechanisms governing carcinoma invasiveness and metastasis has evolved dramatically over the last several years. The previous emphasis on the epithelial-mesenchymal transition as a driver of the migratory properties of single cells has expanded with the observation that carcinoma cell...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-2757

    authors: VanderVorst K,Dreyer CA,Konopelski SE,Lee H,Ho HH,Carraway KL 3rd

    更新日期:2019-04-15 00:00:00

  • Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.

    abstract::The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung cancer specimens. However, the function of DX2 in lung carcinogenesis is obscure. In this study, we found that DX2 expression w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-1025

    authors: Oh AY,Jung YS,Kim J,Lee JH,Cho JH,Chun HY,Park S,Park H,Lim S,Ha NC,Park JS,Park CS,Song GY,Park BJ

    更新日期:2016-08-15 00:00:00

  • bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells.

    abstract::The tumor suppressor gene p53 regulates G1 checkpoint prior to the initiation of DNA synthesis, which can either induce G1 arrest or signal apoptosis. The involvement of p53 in apoptosis may also be related to its ability to down-regulate transcription of the bcl-2 gene. The bcl-2 gene product prevents most types of a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Upadhyay S,Li G,Liu H,Chen YQ,Sarkar FH,Kim HR

    更新日期:1995-10-15 00:00:00

  • Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).

    abstract::7-Hydroxystaurosporine (UCN-01) is a protein kinase inhibitor that is under development as an anticancer agent in the United States and Japan. Long-term exposure of human A549 non-small cell lung cancer cells to UCN-01 furnished cells (A549/UCN) with acquired resistance against UCN-01. In this study, the sensitivity o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sugiyama K,Akiyama T,Shimizu M,Tamaoki T,Courage C,Gescher A,Akinaga S

    更新日期:1999-09-01 00:00:00